{"title":"Mitotane: a friend or a foe before cabozantinib treatment in adrenocortical cancer?","authors":"M. Wierman","doi":"10.1016/s1470-2045(24)00151-7","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":519533,"journal":{"name":"The Lancet. Oncology","volume":"45 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet. Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s1470-2045(24)00151-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}